David Zlotnick, MD, describes the Impella Connect® system, which allows remote visualization of Automated Impella Controller™ (AIC) console data, has been valuable to his team.
Jason Wollmuth, MD and Thom Dahle, MD discuss the RESTORE EF Study, which evaluates EF and clinical status at 60-180 days after high-risk PCI with Impella® support.
Navin K. Kapur, MD, FACC, FSCAI, FAHA, discusses how acute cardiac unloading limits infarct scar formation in the context of the DTU-STEMI Pilot trial and Pivotal trial.
Amir Kaki, MD, discusses large bore femoral and axillary closure techniques as well as vascular closure devices currently on the market and in the pipeline.
Rajiv Tayal, MD, discusses axillary access techniques for large bore procedures as well as other alternative access skills for advanced interventional operators.
This FAQ discusses the causes, incidence, and diagnosis of right heart failure and how the Impella RP(R) heart pump can support the right side of the heart.
The STEMI DTU pivotal trial is a prospective, multicenter, two-arm randomized controlled trial that plans to enroll 668 patients undergoing treatment for a STEMI heart attack.
NPS-1674
The Protected PCI community
is now on HeartRecovery.com
Providing education and training to help health care professionals
recover hearts, oxygenate the body and save lives.
